Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Ambrisentan BNM |
Active Ingredient: | Ambrisentan 5mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
Manufacturer: | AET Laboratories Private Limited, Sangareddy, India |
Product: | Ambrisentan BNM |
Active Ingredient: | Ambrisentan 10mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
Manufacturer: | AET Laboratories Private Limited, Sangareddy, India |
Product: | Octenisept |
Active Ingredients: | Octenidine hydrochloride 1mg/mL Phenoxyethanol 20.09mg/mL |
Dosage Form: | Antiseptic solution |
New Zealand Sponsor: | Schulke New Zealand Limited |
Manufacturer: | Schulke & Mayr GmbH, Norderstedt, Germany |
Product: | Soothing Medicated Throat Lozenges |
Active Ingredients: | Amylmetacresol 0.6mg Dichlorobenzyl alcohol 1.2mg |
Dosage Form: | Lozenge |
New Zealand Sponsor: | Multichem NZ Limited |
Manufacturer: | Makson Health Care (Private) Limited, Mandideep, India |
Product: | Trumenba |
Active Ingredients: | Neisseria meningitidis group B factor H binding protein subfamily A 0.12mg/mL Neisseria meningitidis group B factor H binding protein subfamily B 0.12mg/mL |
Dosage Form: | Suspension for injection |
New Zealand Sponsor: | Pfizer New Zealand Limited |
Manufacturer: | Pfizer Ireland Pharmaceuticals, Clondalkin, Ireland |
Dated this 6th day of September 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).